Evon sells SPNC 28.38: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta; Hospira Granted Temporary Restraining Order Against FDA
The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be participating in two upcoming investor conferences. Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi ... ...
46 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home